Press Release – New York, NY – September 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio (Nasdaq: INMB), a clinical-stage inflammation and immunology …
Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in Closing of $3.5 Million Bridge Financing
Press Release – New York, NY – September 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and …
Sichenzia Ross Ference Carmel LLP Represents Kaival Brands Innovations Group, Inc. in Definitive Merger and Share Exchange Agreement with Delta Corp Holdings Limited
New York, NY - September 25, 2024 - Sichenzia Ross Ference Carmel LLP announced that it has represented Kaival Brands Innovations Group, Inc. ("Kaival Brands" or the "Company"), the exclusive U.S. …
Sichenzia Ross Ference Carmel LLP Represents Elevai Labs, Inc. in Pricing of $8.0 Million Public Offering
New York, NY - September 24, 2024 - Sichenzia Ross Ference Carmel LLP announced that it has represented Elevai Labs, Inc. ("Elevai" or the "Company"), a pioneering force in medical aesthetics, in the …
Sichenzia Ross Ference Carmel LLP Represents Impact Biomedical Inc. in Closing of $4.5 Million Initial Public Offering
Press Release – New York, NY – September 18, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Impact Biomedical Inc. (NYSE: IBO), a company discovering and developing new …
Sichenzia Ross Ference Carmel LLP Represents Tenon Medical Inc. in a $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
New York, NY - September 16, 2024 - Sichenzia Ross Ference Carmel LLP announced that it has represented Tenon Medical, Inc. ("Tenon" or the "Company"), a company transforming care for patients …
